Clinical Research Directory

Inclusion Criteria: Patients were eligible for inclusion in the study if they met all of the following criteria: * Aged 18 years or older, regardless of sex and occupation. * Diagnosed with post-acute ischemic stroke. * Stabilized cardiovascular, respiratory, and neurological conditions, as well as vital signs following the acute phase. * Hemiplegia/Hemiparesis (motor deficit on one side of the body). * Fully conscious and capable of cooperating with clinicians, with a Mini-Mental State Examination (MMSE) score ≥ 20. * Presence of dysphagia, confirmed by a Mann Assessment of Swallowing Ability (MASA) score ≤ 177. * National Institutes of Health Stroke Scale (NIHSS) score ≥ 5. * Clinical diagnosis of ischemic stroke confirmed by brain magnetic resonance imaging (MRI) showing ischemic lesions. * Patients and/or their legal representatives voluntarily provided written informed consent to participate in the study. Exclusion Criteria: * Cerebral venous infarction, hemorrhagic transformation of cerebral infarction. * Stage 3-4 heart failure, cerebral vascular malformations, cerebral air embolism, chronic obstructive pulmonary disease (COPD). * Respiratory failure requiring endotracheal intubation, impaired consciousness. * Concurrent systemic or neuropsychiatric conditions: tuberculosis, psychiatric disorders, HIV/AIDS, epilepsy, esophageal stricture, pyloric stenosis. * Patients who have not received Cerebrolysin treatment during the acute phase. * Non-cooperative patients, participants who fail to complete the full course of treatment, or patients whose clinical symptoms progressively worsen to a life-threatening level during the study.